How does the scFv format benefit viral research applications?

The single-chain variable fragment (scFv) format offers the advantage of smaller size, providing better tissue penetration and binding to target proteins with high specificity and affinity, which is particularly useful for detailed virological analyses.

What is the importance of the specificity of this antibody for Zaire Ebolavirus GP?

The antibody's high specificity to the Ebola virus GP enables it to selectively bind to the virus in complex samples, ensuring accurate detection required for ongoing research and potential therapeutic targeting.

Recombinant Human Anti-ZEBOV GP Antibody scFv Fragment (KZ52)

Specifications

Immunogen
ZBOV Spike glycoprotein

Host Species
Human

Derivation
Human

Type
scFv

Specificity
Tested positive against native ZEBOV GP protein

Species Reactivity
ZEBOV

Clone
KZ52

Applications
Can be useful in applications such as: Neutralization, Western Blot, Enzyme-linked Immunosorbent Assay

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

See other products for "Clone KZ52"

See other products for "GP"

CAT	Product Name	Application	Type
MOB-410	Recombinant Anti-GP Antibody	ELISA, WB, IF, FuncS	IgG
MHH-410	Recombinant Human Anti-GP Antibody	ELISA, Nert, FuncS	IgG
VS-0423-XY11	Human Anti-GP Recombinant Antibody (clone 2.1.1D7)	ELISA	Human IgG
VS-0423-XY12	Human Anti-GP Recombinant Antibody (clone 2.1.7G7)	ELISA	Human IgG
VS-0423-XY13	Human Anti-GP Recombinant Antibody (clone 5.1.9E3)	ELISA	Human IgG

CAT

Product Name

Application

Type

MOB-410

Recombinant Anti-GP Antibody

ELISA, WB, IF, FuncS

IgG

MHH-410

Recombinant Human Anti-GP Antibody

ELISA, Nert, FuncS

IgG

VS-0423-XY11

Human Anti-GP Recombinant Antibody (clone 2.1.1D7)

ELISA

Human IgG

VS-0423-XY12

Human Anti-GP Recombinant Antibody (clone 2.1.7G7)

ELISA

Human IgG

VS-0423-XY13

Human Anti-GP Recombinant Antibody (clone 5.1.9E3)

ELISA

Human IgG

Customer Reviews and Q&As

CAT	Product Name	Application	Type
MOB-410-F(E)	Recombinant Anti-GP Antibody Fab Fragment	WB, FACS, FuncS	Fab
MHH-410-F(E)	Recombinant Human Anti-GP Antibody Fab Fragment	ELISA, WB, FuncS	Fab
PFBC-134	Recombinant Mouse Anti-Z. ebolavirus GP Antibody Fab Fragment (13F6-1-2)	ELISA, Neut	IgG
HPAB-M0096-YC-F(E)	Recombinant Mouse Anti-GP Antibody Fab Fragment (GPE534)	ELISA, WB	Mouse Fab
HPAB-N0105-YC-F(E)	Recombinant Human Anti-GP Antibody Fab Fragment (1B3)	ELISA, FC, Neut, WB	Human Fab

CAT	Product Name	Application	Type
MOB-410-S(P)	Recombinant Anti-GP Antibody scFv Fragment	ELISA, IP, FuncS	scFv
MHH-410-S(P)	Recombinant Human Anti-GP Antibody scFv Fragment	WB, Neut, FuncS	scFv
PFBW-149	Recombinant Human Anti-ZEBOV GP Antibody Fab Fragment (KZ52)	Neut, WB, ELISA	Fab
PSBC-134	Recombinant Mouse Anti-Z. ebolavirus GP Antibody scFv Fragment (13F6-1-2)	ELISA, Neut	scFv
HPAB-N0105-YC-S(P)	Recombinant Human Anti-GP Antibody scFv Fragment (1B3)	ELISA, FC, Neut, WB	Human scFv

CAT	Product Name	Application
MHC-YF150	H-2Ld/MuLV gp70 (SPSYVYHQF) MHC Monomer	MHC Multimer
MHC-YF456	A*02:01/LCMV GP (YLVSIFLHL) MHC Pentamer	FCM
MHC-YF457	H-2Kb/LCMV GP (ISHNFCNL) MHC Pentamer	FCM
MHC-YF458	H-2Db/LCMV GP (SGVENPGGYCL) MHC Pentamer	FCM

Customer Review Q&As

Essential for Ebola Virus Studies

The Mouse Anti-Zaire Ebolavirus GP Antibody scFv Fragment has significantly amplified our research into viral mechanisms. Its precision in detecting the Ebola GP has been indispensable in identifying viral particles and understanding their interaction with host cells, which is crucial for vaccine research.

Reliable Virological Research Tool

This scFv fragment has provided consistent performance in detecting and quantifying Ebola virus particles. Its robustness ensures high-quality results in ELISA, facilitating our analysis of viral replication cycles and entry strategies.